C-C chemokine receptor-7 mediated endocytosis of antibody cargoes into intact cells

Frontiers in Pharmacology

Volumn 4 SEP, Issue , 2013, Pages

  Charest Morin, Xavier ^a   Pépin, Rémy ^a   Gagné Henley, Angélique ^a   Morissette, Guillaume ^a   Lodge, Robert ^b   Marceau, François ^a  

^a LAVAL UNIVERSITY   (Canada)

^b CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

arrestin; CCL19; CCR7; Melanoma; Rab5; Rab7

Indexed keywords

ANTIBODY; BETA ARRESTIN 1; BETA ARRESTIN 2; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CCR7 ANTIBODY; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 4A6; MYC PROTEIN; RAB PROTEIN; RAB7 PROTEIN; UNCLASSIFIED DRUG;

ANTIGEN ANTIBODY COMPLEX; ARTICLE; CONTROLLED STUDY; ENDOCYTOSIS; ENDOSOME; FLUORESCENCE; HUMAN; HUMAN CELL; INTERNALIZATION; MELANOMA CELL; PROTEIN EXPRESSION;

EID: 84885355169     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2013.00122     Document Type: Article

References (24)

1. Bawolak, M. T., Lodge, R., Morissette, G., and Marceau, F. (2011). Bradykinin B2 receptor-mediated transport into intact cells:anti-receptor antibody-based cargoes. Eur. J. Pharmacol. 668, 107-114. doi:10.1016/j.ejphar.2011.06.041.
2. Byers, M. A., Calloway, P. A., Shannon, L., Cunningham, H. D., Smith, S., Li, F., et al. (2008). Arrestin 3 mediates endocytosis of CCR7 following ligation of CCL19 but not CCL21. J. Immunol. 181, 4723-4732.
3. Cameron, P. U., Saleh, S., Sallmann, G., Solomon, A., Wightman, F., Evans, V. A., et al. (2010). Establishment of HIV-1 latency in resting CD4+ T cells depends on chemokine-induced changes in the actin cytoskeleton. Proc. Natl. Acad. Sci. U.S.A. 107, 16934-16939. doi:10.1073/pnas.1002894107.
4. Charest-Morin, X., Fortin, S., Lodge, R., Roy, C., Gera, L., Gaudreault, R. C., et al. (2013). Inhibitory effects of cytoskeleton disrupting drugs and GDP-locked Rab mutants on bradykinin B2 receptor cycling. Pharmacol. Res. 71, 44-52. doi:10.1016/j.phrs.2013.02.007.
5. Fang, L., and Hwang, S. T. (2009). "Roles of CCR7 in cancer biology," in Chemokine Receptors in Cancer, ed. A. M. Fulton (New York, NY:Humana Press), 93-108. doi:10.1007/978-1-60327-267-4_6.
6. Gera, L., Roy, C., Bawolak, M. T., Charest-Morin, X., and Marceau, F. (2012). N-terminal extended conjugates of the agonists and antagonists of both bradykinin receptor subtypes:structure-activity relationship, cell imaging using ligands conjugated with fluorophores and prospect for functionally active cargoes. Peptides 34, 433-446. doi:10.1016/j.peptides.2012.02.007.
7. Gera, L., Roy, C., and Marceau, F. (2013). Bifunctional epitope-agonist ligands of the bradykinin B2 receptor. Biol. Chem. 394, 379-383. doi:10.1515/hsz-2012-0286.
8. Glauser, D. A., and Schlegel, W. (2007). Sequential actions of ERK1/2 on the AP-1 transcription factor allow temporal integration of metabolic signals in pancreatic cells. FASEB J. 21, 3240-3249. doi:10.1096/fj.06-7798com.
9. Höpken, U. E., Foss, H. F., Meyer, D., Hinz, M., Leder, K., Stein, H., et al. (2002). Up-regulation of the chemokine receptor CCR7 in classical but not in lymphocyte-predominant Hodgkin disease correlates with distinct dissemination of neoplastic cells in lymphoid organs. Blood 99, 1109-1116. doi:10.1182/blood. V99.4.1109.
10. Lanati, S., Dunn, D. B., Roussigné, M., Emmett, M. S., Carriere, V., Jullien, D., et al. (2010). Chemotrap-1:an engineered soluble receptor that blocks chemokine-induced migration of metastatic cancer cells in vivo. Cancer Res. 70, 8138-8148. doi:10.1158/0008-5472.CAN-10-0175.
11. Maghazachi, A. A. (2010). Role of chemokines in the biology of natural killer cells. Curr. Top. Microbiol. Immunol. 341, 37-58. doi:10.1007/82_2010_20.
12. Mashino, K., Sadanaga, N., Yamaguchi, H., Tanaka, F., Ohta, M., Shibuta, K., et al. (2002). Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric carcinoma. Cancer Res. 62, 2937-2941.
13. McMahon, G. A., Petitclerc, E., Stefansson, S., Smith, E., Wong, M. K. K., Ginsburg, D., et al. (2001). Plasminogen activator inhibitor-1 regulates tumor growth and angiogenesis. J. Biol. Chem. 276, 33964-33968. doi:10.1074/jbc. M105980200.
14. Moschovakis, G. L., and Förster, R. (2012). Multifaceted activities of CCR7 regulate T-cell homeostasis in health and disease. Eur. J. Immunol. 42, 1949-1955. doi:10.1002/eji.201242614.
15. Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan. M. E., et al. (2001). Involvement of chemokine receptors in breast cancer metastasis. Nature 410, 50-66. doi:10.1038/35065016.
16. Otero, C., Groettrup, M., and Legler, D. F. (2006). Opposite fate of endocytosed CCR7 and its ligands:recycling versus degradation. J. Immunol. 177, 2314-2323.
17. Ott, T. R., Lio, F. M., Olshefski, D., Liu, X. J., Struthers, R. S., and Ling, N. (2004). Determinants of high-affinity binding and receptor activation in the N-terminus of CCL-19 (MIP-3 beta). Biochemistry 43, 3670-3678. doi:10.1021/bi035895h.
18. Shields, J. D., Emmett, M. S., Dunn, D. B. A., Joory, K. D., Sage, L. M., Rigby, H., et al. (2007a). Chemokine-mediated migration of melanoma cells towards lymphatics-a mechanism contributing to metastasis. Oncogene 26, 2997-3005. doi:10.1038/sj.onc.1210114.
19. Shields, J. D., Fleury, M. E., Yong, C., Tomei, A. A., Randolph, G. J., and Swartz, M. A. (2007b). Autologous chemotaxis as a mechanism of tumor cell homing to lymphatics via interstitial flow and autocrine CCR7 signaling. Cancer Cell 11, 526-538. doi:10.1016/j.ccr.2007.04.020.
20. Stenmark, H., Parton, R. G., Steele-Mortimer, O., Lütcke, A., Gruenberg, J., and Zerial, M. (1994). Inhibition of rab5 GTPase activity stimulates membrane fusion in endocytosis. EMBO J. 13, 1287-1296.
21. Teicher, B. A., and Doroshow, J. H. (2012). The promise of antibody-drug conjugates. N. Engl. J. Med. 367, 1847-1848. doi:10.1056/NEJMe1211736.
22. Wang, J., Xi, L., Gooding, W., Godfrey, T. E., and Ferris, R. L. (2005). Chemokine receptors 6 and 7 identify a metastatic expression pattern in squamous cell carcinoma of the head and neck. Adv. Otorhinolaryngol. 62, 121-133.
23. Weber, M., Haschild, R., Scwarz, J., Moussion, C., de Vries, I., Legler, D. F., et al. (2013). Interstitial dendritic cell guidance by haptotactic chemokines gradients. Science 339, 328-332. doi:10.1126/science.1228456.
24. Zhang, J., and Perelson, A. S. (2013). Contribution of follicular dendritic cells to persistent HIV viremia. J. Virol. 87, 7893-7901. doi:10.1128/JVI.00556-13.